Adam J Drelich1, Shan Zhao2, Roger J Guillory1, Jaroslaw W Drelich2, Jeremy Goldman3. 1. Department of Biomedical Engineering, Michigan Technological University, Houghton, MI 49931, USA. 2. Department of Material Science and Engineering, Michigan Technological University, Houghton, MI 49931, USA. 3. Department of Biomedical Engineering, Michigan Technological University, Houghton, MI 49931, USA. Electronic address: jgoldman@mtu.edu.
Abstract
Metallic zinc implanted into the abdominal aorta of rats out to 6months has been demonstrated to degrade while avoiding responses commonly associated with the restenosis of vascular implants. However, major questions remain regarding whether a zinc implant would ultimately passivate through the production of stable corrosion products or via a cell mediated fibrous encapsulation process that prevents the diffusion of critical reactants and products at the metal surface. Here, we have conducted clinically relevant long term in vivo studies in order to characterize late stage zinc implant biocorrosion behavior and products to address these critical questions. We found that zinc wires implanted in the murine artery exhibit steady corrosion without local toxicity for up to at least 20months post-implantation, despite a steady buildup of passivating corrosion products and intense fibrous encapsulation of the wire. Although fibrous encapsulation was not able to prevent continued implant corrosion, it may be related to the reduced chronic inflammation observed between 10 and 20months post-implantation. X-ray elemental and infrared spectroscopy analyses confirmed zinc oxide, zinc carbonate, and zinc phosphate as the main components of corrosion products surrounding the Zn implant. These products coincide with stable phases concluded from Pourbaix diagrams of a physiological solution and in vitro electrochemical impedance tests. The results support earlier predictions that zinc stents could become successfully bio-integrated into the arterial environment and safely degrade within a time frame of approximately 1-2years. STAEMENT OF SIGNIFICANCE: Previous studies have shown zinc to be a promising candidate material for bioresorbable endovascular stenting applications. An outstanding question, however, is whether a zinc implant would ultimately passivate through the production of stable corrosion products or via a cell mediated tissue encapsulation process that prevented the diffusion of critical reactants and products at the metal surface. We found that zinc wires implanted in the murine artery exhibit steady corrosion for up to at least 20months post-implantation. The results confirm earlier predictions that zinc stents could safely degrade within a time frame of approximately 1-2years.
Metallic zinc implanted into the abdominpan class="Chemical">al aorta of rats out to 6months has been demonstrated to degrade while avoiding responses commonly associated with the restenosis of vascular implants. However, major questions remain regarding whether a zinc implant would ultimately passivate through the production of stable corrosion products or via a cell mediated fibrous encapsulation process that prevents the diffusion of critical reactants and products at the metal surface. Here, we have conducted clinically relevant long term in vivo studies in order to characterize late stage zinc implant biocorrosion behavior and products to address these critical questions. We found that zinc wires implanted in the murine artery exhibit steady corrosion without localtoxicity for up to at least 20months post-implantation, despite a steady buildup of passivating corrosion products and intense fibrous encapsulation of the wire. Although fibrous encapsulation was not able to prevent continued implant corrosion, it may be related to the reduced chronic inflammation observed between 10 and 20months post-implantation. X-ray elemental and infrared spectroscopy analyses confirmed zinc oxide, zinc carbonate, and zinc phosphate as the main components of corrosion products surrounding the Zn implant. These products coincide with stable phases concluded from Pourbaix diagrams of a physiological solution and in vitro electrochemical impedance tests. The results support earlier predictions that zinc stents could become successfully bio-integrated into the arterial environment and safely degrade within a time frame of approximately 1-2years. STAEMENT OF SIGNIFICANCE: Previous studies have shown zinc to be a promising candidate material for bioresorbable endovascular stenting applications. An outstanding question, however, is whether a zinc implant would ultimately passivate through the production of stable corrosion products or via a cell mediated tissue encapsulation process that prevented the diffusion of critical reactants and products at the metal surface. We found that zinc wires implanted in the murine artery exhibit steady corrosion for up to at least 20months post-implantation. The results confirm earlier predictions that zinc stents could safely degrade within a time frame of approximately 1-2years.
Authors: Daniel Pierson; Jacob Edick; Aaron Tauscher; Ellen Pokorney; Patrick Bowen; Jesse Gelbaugh; Jon Stinson; Heather Getty; Chee Huei Lee; Jaroslaw Drelich; Jeremy Goldman Journal: J Biomed Mater Res B Appl Biomater Date: 2011-09-08 Impact factor: 3.368
Authors: Michael Haude; Hüseyin Ince; Alexandre Abizaid; Ralph Toelg; Pedro Alves Lemos; Clemens von Birgelen; Evald Høj Christiansen; William Wijns; Franz-Josef Neumann; Christoph Kaiser; Eric Eeckhout; Soo Teik Lim; Javier Escaned; Hector M Garcia-Garcia; Ron Waksman Journal: Lancet Date: 2015-10-12 Impact factor: 79.321
Authors: H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata Journal: Circulation Date: 2000-07-25 Impact factor: 29.690
Authors: Shan Zhao; Jan-M Seitz; Rainer Eifler; Hans J Maier; Roger J Guillory; Elisha J Earley; Adam Drelich; Jeremy Goldman; Jaroslaw W Drelich Journal: Mater Sci Eng C Mater Biol Appl Date: 2017-03-11 Impact factor: 7.328
Authors: Michael Haude; Raimund Erbel; Paul Erne; Stefan Verheye; Hubertus Degen; Dirk Böse; Paul Vermeersch; Inge Wijnbergen; Neil Weissman; Francesco Prati; Ron Waksman; Jacques Koolen Journal: Lancet Date: 2013-03-09 Impact factor: 79.321
Authors: D L Fischman; M B Leon; D S Baim; R A Schatz; M P Savage; I Penn; K Detre; L Veltri; D Ricci; M Nobuyoshi Journal: N Engl J Med Date: 1994-08-25 Impact factor: 91.245
Authors: Song Lin; Xiaolin Ran; Xinhao Yan; Qilong Wang; Jack G Zhou; Tingzhang Hu; Guixue Wang Journal: J Mater Sci Mater Med Date: 2019-11-01 Impact factor: 3.896
Authors: Zeyi Guan; Chase S Linsley; Shuaihang Pan; Gongcheng Yao; Benjamin M Wu; Daniel S Levi; Xiaochun Li Journal: ACS Biomater Sci Eng Date: 2021-12-29
Authors: Roger J Guillory; Ehsan Mostaed; Alexander A Oliver; Lea M Morath; Elisha J Earley; Katie L Flom; Timothy M Kolesar; Ali Mostaed; Henry D Summers; Maria P Kwesiga; Jaroslaw W Drelich; Kent D Carlson; Dan Dragomir-Daescu; Jeremy Goldman Journal: Acta Biomater Date: 2022-03-31 Impact factor: 10.633